Moleculin Biotech, Inc. short interest in 2022
In 2022, Moleculin Biotech, Inc.'s disclosed short interest ran from 1.86% of shares outstanding on 14 Jan 2022 to 0.41% on 30 Dec 2022, a change of -1.45 percentage points. The year's high was 1.86% on 14 Jan 2022 and its low 0.18% on 31 Oct 2022, averaging 0.77% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.41 days on 15 Mar 2022. Full history: Moleculin Biotech, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2025
2022 in figures
- Start of year
- 1.86% (14 Jan 2022)
- End of year
- 0.41% (30 Dec 2022)
- Change
- -1.45 pp
- High
- 1.86% (14 Jan 2022)
- Low
- 0.18% (31 Oct 2022)
- Average
- 0.77%
- Highest days to cover
- 4.41 (15 Mar 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 1.86% | 3.14 | |
| 31 Jan 2022 | 1.72% | 2.68 | |
| 15 Feb 2022 | 1.55% | 4.05 | |
| 28 Feb 2022 | 1.69% | 3.85 | |
| 15 Mar 2022 | 1.53% | 4.41 | |
| 31 Mar 2022 | 1.46% | 3.84 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 1.46% | 3.92 | |
| 29 Apr 2022 | 1.05% | 2.62 | |
| 13 May 2022 | 0.66% | 2.30 | 10-Q filed, results (8-K) |
| 31 May 2022 | 0.87% | 4.30 | |
| 15 Jun 2022 | 0.53% | 3.67 | |
| 30 Jun 2022 | 0.33% | 2.11 | |
| 15 Jul 2022 | 0.41% | 3.59 | |
| 29 Jul 2022 | 0.19% | 1.00 | |
| 15 Aug 2022 | 0.35% | 1.38 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 0.55% | 1.12 | |
| 15 Sep 2022 | 0.33% | 1.00 | |
| 30 Sep 2022 | 0.21% | 1.00 | |
| 14 Oct 2022 | 0.20% | 1.20 | |
| 31 Oct 2022 | 0.18% | 1.00 | |
| 15 Nov 2022 | 0.24% | 1.02 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 0.31% | 1.00 | |
| 15 Dec 2022 | 0.28% | 1.00 | |
| 30 Dec 2022 | 0.41% | 1.03 |
See also: Moleculin Biotech, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.